Limited access to GLP-1s in low-income and high-obesity regions threatens to widen existing health inequities, particularly in rates of diabetes, cardiovascular disease, and mobility-related conditions
doi: 10.1161/CIRCHEARTFAILURE.109.900282
In preclinical models and early human data, it has been hypothesised that the additional glucagon receptor activity may contribute to increased energy expenditure and broader metabolic effects
These sequence modifications enhance peptide stability in experimental systems and allow sustained interaction with multiple receptor classes during signaling assays
Several studies have reported HRQoL evaluations for patients affected by pain and other pathologies that have been treated with cannabis, but, unfortunately, the majority of these studies have limitations and cannot therefore be considered conclusive
sip water through the day